Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM JG Viniegra, N Martínez, P Modirassari, JH Losa, CP Cobo, VJSA Lobo, ... Journal of Biological Chemistry 280 (6), 4029-4036, 2005 | 351 | 2005 |
Role of the p38 MAPK pathway in cisplatin-based therapy JH Losa, CP Cobo, JG Viniegra, VJSA Lobo, R Sanchez-Prieto Oncogene 22 (26), 3998-4006, 2003 | 228 | 2003 |
Regulation of p73 by c-Abl through the p38 MAP kinase pathway R Sanchez-Prieto, VJ Sanchez-Arevalo, JM Servitja, JS Gutkind Oncogene 21 (6), 974-979, 2002 | 146 | 2002 |
BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis L Richart, E Carrillo-de Santa Pau, A Río-Machín, MP De Andrés, ... Nature communications 7 (1), 10153, 2016 | 133 | 2016 |
RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway D Alonso-Curbelo, E Riveiro-Falkenbach, E Pérez-Guijarro, M Cifdaloz, ... Cancer cell 26 (1), 61-76, 2014 | 116 | 2014 |
Transcriptional regulation by NR5A2 links differentiation and inflammation in the pancreas I Cobo, P Martinelli, M Flández, L Bakiri, M Zhang, ... Nature 554 (7693), 533-537, 2018 | 104 | 2018 |
Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells C Barceló, J Etchin, MR Mansour, T Sanda, MM Ginesta, VJSA Lobo, ... Gastroenterology 147 (4), 882-892. e8, 2014 | 72 | 2014 |
Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer E Wauters, VJ Sanchez-Arevalo Lobo, AV Pinho, A Mawson, D Herranz, ... Cancer research 73 (7), 2357-2367, 2013 | 70 | 2013 |
Enhanced antiangiogenic therapy with antibody‐collagen XVIII NC1 domain fusion proteins engineered to exploit matrix remodeling events VJ Sánchez‐Arévalo Lobo, ÁM Cuesta, L Sanz, M Compte, P García, ... International journal of cancer 119 (2), 455-462, 2006 | 48 | 2006 |
Modulation of PI3K/Akt pathway by E1a mediates sensitivity to cisplatin JG Viniegra, JH Losa, VJ Sanchez-Arevalo, CP Cobo, VMF Soria, ... Oncogene 21 (46), 7131-7136, 2002 | 42 | 2002 |
Choline Kinase Alpha (CHKα) as a therapeutic target in pancreatic ductal adenocarcinoma: Expression, predictive value, and sensitivity to inhibitors JM Mazarico, VJ Sanchez-Arevalo Lobo, R Favicchio, W Greenhalf, ... Molecular cancer therapeutics 15 (2), 323-333, 2016 | 34 | 2016 |
Dual regulation of Myc by Abl VJ Sanchez-Arévalo Lobo, M Doni, A Verrecchia, S Sanulli, G Fagà, ... Oncogene 32 (45), 5261-5271, 2013 | 34 | 2013 |
c-MYC partners with BPTF in human cancer L Richart, FX Real, VJ Sanchez-Arevalo Lobo Molecular & cellular oncology 3 (3), e1152346, 2016 | 29 | 2016 |
Modulation of the p38 MAPK (mitogen-activated protein kinase) pathway through Bcr/Abl: implications in the cellular response to Ara-C VJ Sanchez-arevalo lobo, CI Aceves luquero, L Alvarez-Vallina, ... Biochemical Journal 387 (1), 231-238, 2005 | 27 | 2005 |
Adenovirus E1a protein enhances the cytotoxic effects of the herpes thymidine kinase-ganciclovir system C Parada, J Hernández Losa, J Guinea, V Sánchez-Arévalo, ... Cancer Gene Therapy 10 (2), 152-160, 2003 | 25 | 2003 |
MYC degradation: deubiquitinating enzymes enter the dance B Amati, VJ Sanchez-Arévalo Lobo Nature cell biology 9 (7), 729-731, 2007 | 24 | 2007 |
c-Myc downregulation is required for preacinar to acinar maturation and pancreatic homeostasis VJSA Lobo, LC Fernández, E Carrillo-de-Santa-Pau, L Richart, I Cobo, ... Gut 67 (4), 707-718, 2018 | 22 | 2018 |
Mnk1 is a novel acinar cell-specific kinase required for exocrine pancreatic secretion and response to pancreatitis in mice J Cendrowski, VJSA Lobo, M Sendler, A Salas, JP Kühn, X Molero, ... Gut 64 (6), 937-947, 2015 | 15 | 2015 |
Molecular alterations in pancreatic cancer: Transfer to the clinic Y Rodríguez Gil, P Jiménez Sánchez, R Muñoz Velasco, A García García, ... International Journal of Molecular Sciences 22 (4), 2077, 2021 | 13 | 2021 |
The role of the proto-oncogene c-myc in B lymphocyte differentiation D Fernandez, VJ Sánchez-Arevalo, IM de Alboran Critical Reviews™ in Immunology 32 (4), 2012 | 10 | 2012 |